Procyon Corp (PCYN) financial statements (2022 and earlier)
Company profile
| Business Address |
1300 S HIGHLAND AVE CLEARWATER, FL 33756 |
| State of Incorp. | CO |
| Fiscal Year End | June 30 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2021 TTM | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 1,087 | 1,507 | 821 | 290 | 270 | 173 | ||
| Cash and cash equivalents | 1,087 | 1,507 | 821 | 290 | 270 | 173 | ||
| Restricted cash and investments | 112 | |||||||
| Receivables | 419 | 497 | 311 | 420 | 372 | 392 | ||
| Inventory, net of allowances, customer advances and progress billings | 854 | 591 | 759 | 485 | 417 | 507 | ||
| Inventory | 854 | 591 | 759 | 485 | 417 | 507 | ||
| Deferred tax assets | ✕ | ✕ | ✕ | 243 | ||||
| Other undisclosed current assets | 248 | 276 | 183 | 398 | 325 | 166 | ||
| Total current assets: | 2,607 | 2,872 | 2,074 | 1,594 | 1,384 | 1,592 | ||
| Noncurrent Assets | ||||||||
| Inventory, Noncurrent | 182 | 263 | 84 | |||||
| Operating lease, right-of-use asset | 795 | 882 | 30 | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 144 | 109 | 453 | 488 | 512 | 514 | ||
| Intangible assets, net (including goodwill) | 17 | 17 | 17 | |||||
| Intangible assets, net (excluding goodwill) | 17 | 17 | 17 | |||||
| Deposits noncurrent assets | 28 | 3 | 4 | |||||
| Deferred income tax assets | 82 | 120 | 160 | ✕ | ✕ | ✕ | ||
| Other noncurrent assets | 353 | 462 | 513 | |||||
| Other undisclosed noncurrent assets | 112 | |||||||
| Total noncurrent assets: | 1,248 | 1,396 | 748 | 841 | 974 | 1,138 | ||
| TOTAL ASSETS: | 3,855 | 4,267 | 2,822 | 2,435 | 2,358 | 2,730 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 38 | 414 | 289 | 228 | 229 | 436 | ||
| Accounts payable | 38 | 121 | ||||||
| Accrued liabilities | 61 | 53 | 55 | 50 | 45 | |||
| Employee-related liabilities | 315 | 203 | 174 | 179 | 270 | |||
| Other undisclosed accounts payable and accrued liabilities | 39 | 34 | ||||||
| Debt | 57 | 2 | 4 | |||||
| Other undisclosed current liabilities | 391 | 322 | 167 | 147 | 95 | |||
| Total current liabilities: | 429 | 736 | 514 | 376 | 326 | 440 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 574 | 654 | 144 | 2 | ||||
| Long-term debt, excluding current maturities | 144 | |||||||
| Capital lease obligations | ✕ | ✕ | ✕ | 2 | ||||
| Operating lease, liability | 574 | 654 | ✕ | ✕ | ✕ | |||
| Other undisclosed noncurrent liabilities | (574) | (654) | ||||||
| Total noncurrent liabilities: | 574 | 654 | 144 | 2 | ||||
| Total liabilities: | 1,002 | 1,389 | 658 | 376 | 326 | 442 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent, including: | 2,853 | 2,878 | 2,164 | 2,059 | 2,032 | 2,288 | ||
| Common stock | 4,445 | 4,445 | 4,445 | 4,445 | 4,435 | 4,435 | ||
| Additional paid in capital | 36 | 36 | 16 | 16 | 16 | 16 | ||
| Accumulated deficit | (1,755) | (1,729) | (2,424) | (2,529) | (2,556) | (2,300) | ||
| Other undisclosed stockholders' equity attributable to parent | 127 | 127 | 127 | 127 | 137 | 137 | ||
| Total stockholders' equity: | 2,853 | 2,878 | 2,164 | 2,059 | 2,032 | 2,288 | ||
| TOTAL LIABILITIES AND EQUITY: | 3,855 | 4,267 | 2,822 | 2,435 | 2,358 | 2,730 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2021 TTM | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 5,052 | 4,720 | 4,334 | 4,191 | 4,020 | 4,012 | |
| Cost of revenue (Cost of Goods and Services Sold) | (1,503) | (1,331) | (1,135) | (1,142) | (1,085) | (1,263) | |
| Gross profit: | 3,549 | 3,389 | 3,199 | 3,050 | 2,936 | 2,750 | |
| Operating expenses | (3,636) | (3,162) | (3,046) | (2,953) | (2,809) | (2,720) | |
| Operating income (loss): | (88) | 227 | 153 | 97 | 127 | 30 | |
| Nonoperating income (expense) | 1,016 | 507 | 7 | 2 | 1 | (1) | |
| Investment income, nonoperating | 0 | 1 | 2 | 2 | 1 | 2 | |
| Other nonoperating income | 203 | 10 | |||||
| Interest and debt expense | 203 | (3) | |||||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 406 | 3 | |||||
| Income from continuing operations before equity method investments, income taxes: | 1,335 | 937 | 160 | 99 | 128 | 29 | |
| Other undisclosed loss from continuing operations before income taxes | (406) | (203) | |||||
| Income from continuing operations before income taxes: | 929 | 734 | 160 | 99 | 128 | 29 | |
| Income tax expense | (122) | (39) | (48) | (72) | (383) | (17) | |
| Net income (loss) attributable to parent: | 807 | 694 | 112 | 27 | (256) | 12 | |
| Preferred stock dividends and other adjustments | (17) | (17) | (17) | (17) | (18) | 13 | |
| Net income (loss) available to common stockholders, diluted: | 790 | 678 | 95 | 10 | (273) | 26 | |
Comprehensive Income ($ in thousands)
| 12/31/2021 TTM | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | 807 | 694 | 112 | 27 | (256) | 12 | |
| Comprehensive income (loss), net of tax, attributable to parent: | 807 | 694 | 112 | 27 | (256) | 12 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.